Pipeline & asset strategy
Translate dermatology science into differentiated target product profiles, evidence plans and investment decisions.
Medical transformation · Dermatology
Fractional Chief Medical Officer for dermatology, biotech and medtech.
Senior medical leadership for pipeline strategy, clinical development, launch and lifecycle management—without the cost of a full-time executive hire.
Led by Carlos Peralta, MD, MBA, FAAD · 25 years across the dermatology product lifecycle
Built forBiotechPharmaMedtechVenture capitalHealth entrepreneursClinic groups
01 / The proposition
Big-pharma medical leadership. Precisely sized to the problem.
Functional Dermatology Partner™ brings a board-certified dermatologist into the decisions that shape an asset’s future. You gain the judgment, network and execution mandate of a senior medical executive—when you need it, for as long as it creates value.
Where FDP creates value
From scientific possibility to patient impact.
One integrated medical perspective across the product lifecycle, joining science, strategy and commercial reality.
Clinical development
Bring specialist medical judgment to indication selection, endpoints, trial design and external expert engagement.
Launch & lifecycle
Connect medical strategy, market reality and patient needs from pre-launch through brand optimization.
Medical due diligence
Pressure-test assets, platforms and devices with an operator’s view of the science, the clinic and the market.
Carlos PeraltaMD · MBA · FAAD
Operator, not outside observer
A dermatologist who has worked across the entire value chain.
Carlos Peralta combines specialist clinical training with 25 years inside dermatology drug development, medical affairs, launches and lifecycle strategy. FDP adds a senior seat to your decision-making process—with the mandate to execute, not merely advise.
Meet Carlos and review his experienceSolutions in practice
Experience is most useful when it becomes a repeatable way to solve problems.
Selected examples from 25 years across medicine, drug development, medical leadership and healthcare innovation.
AI-supported medical intelligence
Turning scientific information overload into faster, more usable medical insight—while learning why timing, ownership and technology maturity determine whether innovation scales.
A translational research ecosystem
Connecting industry, an academic medical center and public institutions around training, early research capabilities and a shared development agenda.
Open innovation in healthcare
Creating structured programs that brought clinicians, scientists, technology experts and entrepreneurs together around problems worth solving.
Flexible by design
Engage at the level the decision requires.
From a focused strategic session to embedded fractional medical leadership. Scope and duration follow the business need.
Strategic session
2–4 hoursA high-stakes decision, investment thesis or product question.
Strategic advisor
2–4 days / monthOngoing senior guidance without adding executive headcount.
Fractional CMedO
1–2 days / weekEmbedded medical leadership through active development or launch.
Due diligence
Fixed projectIndependent medical-scientific assessment with a clear deliverable.
Detailed scope and commercial terms are agreed for each engagement.
02 / International reach
Amsterdam · Gdańsk · Madrid · Marbella · Buenos Aires
Headquartered in Amsterdam, working with organizations across Europe and the Americas.
A focused first conversation
What medical decision is slowing your next move?
Share the asset, challenge or decision. We will identify whether a strategic session, project or fractional role is the right fit.
Start the conversation drperaltapascualcarlos@gmail.com